Ridwan B. Ayinde, NPC

Ridwan Ayinde practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Ridwan Ayinde's NPI, 1922646736, was assigned on December 12, 2019. Ridwan Ayinde holds Texas license AP140757.

Ridwan Ayinde's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Ridwan Ayinde's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dmand AI tracks the electronic health record (EHR) system at each site where Ridwan Ayinde practices. Vendor and product names are available with a free account.

Nurse practitioner is Ridwan Ayinde's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Ridwan Ayinde is licensed in Texas.

CMS counts 19 Medicare patients who saw Ridwan Ayinde in 2024. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 3.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ridwan Ayinde's median patient age at 66, with 43% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Ridwan Ayinde for performance year 2024, reported as part of a group. Ridwan Ayinde accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Ridwan Ayinde from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $37.